Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Natco Pharma Limited
Press Release Mar 07 2022
Business
Mar 7 2022
4 min read

Press Release Mar 07 2022

Natco Pharma Limited has informed the Exchange about press release dated 07-Mar-2022 titled NATCO Announces Launch of the First Generic Version of Revlimid�� (Lenalidomide capsules), in the U.S. market

View Attachment